Regulate with the Times
March 21, 2020
Ancillary material quality has become critical to the clinical advancement of cell and gene therapies. We need a regulatory framework that ensures safety, while also recognizing the growing cost burden on suppliers
1 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
